Tag: heterozygous familial hypercholesterolemia

1. Evolocumab successfully reduced low density lipoprotein (LDL) cholesterol levels in pediatric patients with heterozygous familial hypercholesterolemia. 2. Non- high density lipoprotein and apolipoprotein B levels were also improved in the evolocumab group. Evidence Rating Level: 1 (Excellent) Study Rundown: In the adult patient population with hyperlipidemia, human monoclonal antibodies that inhibitor...
1. Evolocumab successfully reduced low density lipoprotein (LDL) cholesterol levels in pediatric patients with heterozygous familial hypercholesterolemia. 2. Non- high density lipoprotein and apolipoprotein B levels were also improved in the evolocumab group. Evidence Rating Level: 1 (Excellent) Study Rundown: In the adult patient population with hyperlipidemia, human monoclonal antibodies that inhibitor...